Advantage Alpha Capital Partners LP Has $2.67 Million Stock Position in Trupanion, Inc. (NASDAQ:TRUP)

Advantage Alpha Capital Partners LP lessened its holdings in Trupanion, Inc. (NASDAQ:TRUP) by 22.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 63,499 shares of the financial services provider’s stock after selling 18,414 shares during the quarter. Advantage Alpha Capital Partners LP owned 0.15% of Trupanion worth $2,666,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of TRUP. Vanguard Group Inc. lifted its position in shares of Trupanion by 0.9% during the 1st quarter. Vanguard Group Inc. now owns 3,673,791 shares of the financial services provider’s stock worth $101,433,000 after buying an additional 32,485 shares during the last quarter. FMR LLC lifted its holdings in shares of Trupanion by 55,963.7% in the third quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock worth $49,213,000 after acquiring an additional 1,170,202 shares during the last quarter. Marshall Wace LLP lifted its holdings in shares of Trupanion by 11.9% in the second quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock worth $32,181,000 after acquiring an additional 116,496 shares during the last quarter. Renaissance Technologies LLC acquired a new stake in shares of Trupanion in the 2nd quarter valued at approximately $4,739,000. Finally, Dimensional Fund Advisors LP grew its holdings in shares of Trupanion by 24.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 137,833 shares of the financial services provider’s stock valued at $4,052,000 after purchasing an additional 26,941 shares during the last quarter.

Insider Activity

In other Trupanion news, Director Murray B. Low sold 2,000 shares of the firm’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $52.67, for a total value of $105,340.00. Following the transaction, the director now directly owns 131,513 shares of the company’s stock, valued at approximately $6,926,789.71. This trade represents a 1.50 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Margaret Tooth sold 7,500 shares of Trupanion stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total transaction of $348,600.00. Following the transaction, the chief executive officer now owns 99,984 shares of the company’s stock, valued at $4,647,256.32. This represents a 6.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 21,416 shares of company stock worth $1,085,488 in the last three months. Company insiders own 5.50% of the company’s stock.

Analysts Set New Price Targets

TRUP has been the topic of a number of research analyst reports. Evercore ISI upgraded shares of Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. Stifel Nicolaus raised their price objective on Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a report on Monday, September 23rd. Piper Sandler upped their target price on Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a report on Thursday, October 31st. Northland Securities lifted their price target on Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research note on Thursday, October 31st. Finally, Bank of America boosted their price target on Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a report on Friday, September 20th. Three research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $44.67.

Trupanion Price Performance

Shares of NASDAQ TRUP opened at $53.46 on Tuesday. The company has a market capitalization of $2.26 billion, a PE ratio of -167.06 and a beta of 1.69. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.40. Trupanion, Inc. has a twelve month low of $19.69 and a twelve month high of $57.90. The firm has a fifty day simple moving average of $49.19 and a 200 day simple moving average of $39.67.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.09. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The firm had revenue of $327.50 million during the quarter, compared to analyst estimates of $321.79 million. During the same period last year, the company posted ($0.10) EPS. The business’s quarterly revenue was up 14.6% on a year-over-year basis. On average, sell-side analysts forecast that Trupanion, Inc. will post -0.23 EPS for the current year.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.